Drugs / EMLA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03865147 | Jan → Jul 2019 | — | Medical Ethics UK Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03865147 ↗ |
| Route | Topical | “EMLA cream (1-2g /10cm2). administered to the wound for 60 minutes under an occlusive dressing” NCT03865147 ↗ |